Biohaven Stock Stumbles As Protein-Degrading Drug Falls Short Of Expectations In Early-Stage Study
Biohaven Ltd. · PHARMACEUTICAL PREPARATIONS · Now $11.43
+21% in 7d after detection
Post-detection moves
1h
—
1d
-1.2%
3d
+12%
7d
+21%
30d
—
Get alerts like this in real time
Push notifications the moment a signal fires. No spam, no crypto, no fluff.
Download for iOS